All In Biotech

Free tool

FAERS Monitor: Arimidex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022214 or its brand name (Arimidex, Anastrozole). Reports on generic versions are filed under their own applications.

Reports

37,157

Serious

25,421

68% of reports

Hospitalization

8,122

Death reported

2,478

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue3,541
  • arthralgia3,276
  • nausea2,844
  • alopecia2,620
  • diarrhoea2,441
  • pain1,887
  • headache1,836
  • asthenia1,647
  • dyspnoea1,620
  • dizziness1,571
  • pain in extremity1,461
  • hot flush1,445
  • malignant neoplasm progression1,426
  • vomiting1,376
  • malaise1,360

Reports by year received

View as table
YearReports
2004278
2005385
2006549
20071,232
20081,491
20091,838
20101,308
20111,385
20121,449
2013965
2014994
20151,268
20161,609
20171,936
20182,254
20192,548
20202,234
20212,081
20222,315
20232,611
20242,273
20252,267
20261,886

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,017,002 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hot flushSignal1,44511.010.512,985
malignant neoplasm progressionSignal1,4268.07.68,619
alopeciaSignal2,6207.67.415,053
arthralgiaSignal3,2764.54.38,983
pain in extremitySignal1,4612.82.71,725
fatigueSignal3,5412.62.53,545
astheniaSignal1,6472.52.41,482
diarrhoeaSignal2,4412.12.11,532
nauseaSignal2,8442.02.01,555
dizziness1,5711.81.7553
malaise1,3601.81.7451
pain1,8871.71.7611
headache1,8361.71.6494
vomiting1,3761.71.6366
dyspnoea1,6201.61.5395

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.